Kilitch Drugs (India) Ltd 524500.BO
Last Updated: Jul 17, 12:00 AM·BSE
524500.BO Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Kilitch Drugs (India) Ltd is classified as halal.
HALAL
Report Source: 2026 Annual Report
Kilitch Drugs (India) Ltd. Stock Analysis 524500.BO
India Health Care Micro Cap Report: Kilitch Drugs (India) Ltd. engages in the developing, manufacturing, and marketing of pharmaceuticals, medicinal chemical, and botanical products. The firm is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The firm offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. The company offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. The company provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. The company offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
Read More Kilitch Drugs (India) Ltd (524500.BO) Chart
Key Statistics of Kilitch Drugs (India) Ltd (524500.BO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹184.00Volume
4654.00P/E Ratio (TTM)
21.05Financial Metrics & Statements of Kilitch Drugs (India) Ltd (524500.BO)
Super Investors Invested in Kilitch Drugs (India) Ltd (524500.BO)
FAQ's for Kilitch Drugs (India) Ltd (524500.BO)
- As of July 2026, Kilitch Drugs (India) Ltd 524500.BO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kilitch Drugs (India) Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kilitch Drugs (India) Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kilitch Drugs (India) Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kilitch Drugs (India) Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kilitch Drugs (India) Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.